The Design and Development of Fesoterodine as a Prodrug of 5- Hydroxymethyl Tolterodine (5-HMT), the Active Metabolite of Tolterodine

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|16|33|4481-4489

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.33, 2009-11, pp. : 4481-4489

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tolterodine

By Hills C.J.   Winter S.A.   Balfour J.A.  

Drugs, Vol. 55, Iss. 6, 1998-06 ,pp. : 813-820

Adis International

Access to resources Recommend Favorite

Design and Characterization of Sustained Release Mucoadhesive Microspheres of Tolterodine Tartrate

By  

Current Drug Delivery, Vol. 10, Iss. 4, 2013-08 ,pp. : 413-426

Bentham Science Publishers

Access to resources Recommend Favorite

Tolterodine: A Viewpoint by Paul Abrams

By Abrams P.  

Drugs, Vol. 55, Iss. 6, 1998-06 ,pp. : 821-822

Adis International

Access to resources Recommend Favorite

Tolterodine for the treatment of overactive bladder

By Salvatore Stefano   Serati Maurizio   Bolis Pierfrancesco  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1249-1255

Informa Healthcare

Access to resources Recommend Favorite

Effective Prodrug Liposome and Conversion to Active Metabolite

By  

Current Drug Metabolism, Vol. 1, Iss. 1, 2000-07 ,pp. : 31-48

Bentham Science Publishers

Access to resources Recommend Favorite